41. Giant cell arteritis Clinical trials / Disease details


Clinical trials : 128 Drugs : 139 - (DrugBank : 36) / Drug target genes : 33 - Drug target pathways : 124

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03765788
(ClinicalTrials.gov)
January 30, 20193/12/2018A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell ArteritisA Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab (AIN457) in Patients With Giant Cell Arteritis (TitAIN)Giant Cell ArteritisDrug: Secukinumab 300 mg, s.c.;Drug: Prednisolone;Drug: PlaceboNovartis PharmaceuticalsNULLCompleted50 YearsN/AAll52Phase 2Germany